Bicara Therapeutics Inc. ...

NASDAQ: BCAX · Real-Time Price · USD
11.43
0.10 (0.88%)
At close: Aug 14, 2025, 3:59 PM
11.41
-0.17%
Pre-market: Aug 15, 2025, 08:45 AM EDT

Bicara Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-68M -51.98M -37.84M
Depreciation & Amortization
56K 19K 10K
Stock-Based Compensation
7.4M 1.9M 810K
Other Working Capital
-16.77M -961K -922K
Other Non-Cash Items
-77K 14.06M n/a
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
-14.13M -9.62M 4.95M
Operating Cash Flow
-74.75M -45.63M -32.08M
Capital Expenditures
-71K -586K -192K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
62K n/a n/a
Investing Cash Flow
-9K -586K -192K
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
1.6M n/a n/a
Financial Cash Flow
334.03M 272.5M 31.7M
Net Cash Flow
259.27M 226.28M -573K
Free Cash Flow
-74.82M -46.21M -32.27M